TY - JOUR
KW - COVID-19
KW - Harm Reduction
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pandemics
KW - SARS-CoV-2
KW - emergency
KW - Low-threshold
KW - opioid use disorder
KW - Opioids
KW - telehealth
KW - treatment
AU - N. Krawczyk
AU - A. Fawole
AU - J. Yang
AU - B. Tofighi
A1 - 
AD - Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, 180 Madison Ave, Room 4-12, New York, NY, USA. noa.krawczyk@nyulangone.org.; New York University, School of Global Public Health, New York, NY, USA.; NYU Grossman School of Medicine, New York, NY, USA.; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
BT - Addiction science & clinical practice
C5 - HIT & Telehealth; Opioids & Substance Use
CP - 1
DO - 10.1186/s13722-021-00275-1
IS - 1
JF - Addiction science & clinical practice
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2021
SN - 1940-0640; 1940-0632; 1940-0632
SP - 68
T1 - Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
T2 - Addiction science & clinical practice
TI - Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
U1 - HIT & Telehealth; Opioids & Substance Use
U2 - 34774106
U3 - 10.1186/s13722-021-00275-1
VL - 16
VO - 1940-0640; 1940-0632; 1940-0632
Y1 - 2021
Y2 - Nov 13
ER -